Downregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotide correlates with tumor drug uptake

Cancer Biology and Therapy

Volumn 7, Issue 9, 2008, Pages 1492-1497

  Zhang, Jianjun ^a   Zafrullah, Mohammad ^a   Yang, Xia ^a   Yin, Xianglei ^a   Zhang, Zhigang ^a   Fuks, Zvi ^a   Kolesnick, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Antisense oligonucleotide; Drug uptake; ELISA; KSR1; Pancreatic cancer

Indexed keywords

ANTIINFECTIVE AGENT; ANTISENSE OLIGONUCLEOTIDE; KINASE SUPPRESSOR OF RAS1; UNCLASSIFIED DRUG; KSR 1 PROTEIN KINASE; KSR-1 PROTEIN KINASE; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DNA HYBRIDIZATION; DOWN REGULATION; DRUG UPTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE REPRESSION; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; WESTERN BLOTTING; XENOGRAFT; ANIMAL; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NUDE MOUSE; PANCREAS TUMOR; SENSITIVITY AND SPECIFICITY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MICE; MICE, NUDE; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; PROTEIN KINASES; SENSITIVITY AND SPECIFICITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 52149087172     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kornfeld K, Guan KL, Horvitz HR. The Caenorhabditis elegans gene mek-2 is required for vulval induction and encodes a protein similar to the protein kinase MEK. Genes Dev 1995; 9:756-68.
2. Kornfeld K, Hom DB, Horvitz HR. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell 1995; 83:903-13.
3. Sundaram M, Han M. The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction. Cell 1995; 83:889-901.
4. Therrien M, Chang HC, Solomon NM, Karim FD, Wassarman DA, Rubin GM. KSR, a novel protein kinase required for RAS signal transduction. Cell 1995; 83:879-88.
5. Lozano J, Xing R, Cai Z, Jensen HL, Trempus C, Mark W, Cannon R, Kolesnick R. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res 2003; 63:4232-8.
6. Clapèron A and Therrien M. KSR and CNK: Two scaffolds regulating RAS-mediated RAF activation. Oncogene 2007; 26:3143-58.
7. Xing HR, Cordon-Cardo C, Deng X, Tong W, Campodonico L, Fuks Z, Kolesnick R. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat Med 2003; 9:1266-8.
8. Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G, Haglund C. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005; 54:385-7.
9. Parris GE. Why G3139 works poorly in cancer trials but might work well against HIV. Med Hypotheses 2007; 69:537-40.
10. Hanai K, Kurokawa T, Minakuchi Y, Maeda M, Nagahara S, Miyata T, Ochiya T, Sano A. Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease. Hum Gene Ther 2004; 15:263-72.
11. Tamm I, Dorken B, Hartmann G. Antisense therapy in oncology: new hope for an old idea? Lancet 2001; 358:489-97.
12. Kim R, Tanabe K, Emi M, Uchida Y, Toge T. Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review). Int J Oncol 2004; 24:5-17.
13. Cotter FE. Antisense therapy of hematologic malignancies. Semin Hematol 1999; 36:9-1
14. Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di Stefano F, Cotter FE. Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J Clin Oncol 2000; 18:1812-23.
15. Tamm I, Wagner M. Antisense therapy in clinical oncology: preclinical and clinical experiences. Mol Biotechnol 2006; 33:221-38.
16. Bigelow JC, Chrin LR, Mathews LA, McCormick JJ. High-performance liquid chromatographic analysis of phosphorothioate analogues of oligodeoxynucleotides in biological fluids. J Chromatogr 1990; 533:133-40.
17. Chen SH, Qian M, Brennan JM, Gallo JM. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis. J Chromatogr B Biomed Sci Appl 1997; 692:43-51.
18. Leeds JM, Graham MJ, Truong L, Cummins LL. Quantitation of phosphorothioate oligonucleotides in human plasma. Anal Biochem 1996; 235:36-43.
19. Reyderman L, Stavchansky S. Determination of single-stranded oligodeoxynucleotides by capillary gel electrophoresis with laser induced fluorescence and on column derivatization. J Chromatogr A 1996; 755:271-80.
20. Bruenner BA, Yip TT, Hutchens TW. Quantitative analysis of oligonucleotides by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 1996; 10:1797-801.
21. de Serres M, McNulty MJ, Christensen L, Zon G, Findlay JW. Development of a novel scintillation proximity competitive hybridization assay for the determination of phosphorothioate antisense oligonucleotide plasma concentrations in a toxicokinetic study. Anal Biochem 1996; 233:228-33.
22. Deverre JR, Boutet V, Boquet D, Ezan E, Grassi J, Grognet JM. A competitive enzyme hybridization assay for plasma determination of phosphodiester and phosphorothioate antisense oligonucleotides. Nucleic Acids Res 1997; 25:3584-9.
23. Boutet V, Delaunay V, De Oliveira MC, Boquet D, Grognet JM, Grassi J, Deverre JR. Real-time monitoring of the hybridization reaction: application to the quantification of oligonucleotides in biological samples. Biochem Biophys Res Commun 2000; 268:92-8.
24. Yu RZ, Baker B, Chappell A, Geary RS, Cheung E, Levin AA. Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma. Anal Biochem 2002; 304:19-25.
25. Wei X, Dai G, Marcucci G, Liu Z, Hoyt D, Blum W, Chan KK. A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices. Pharm Res 2006; 23:1251-64.
26. Watanabe TA, Geary RS, Levin AA. Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302). Oligonucleotides 2006; 16:169-80.